# A Study of MEDI7352 in Painful Osteoarthritis of the Knee

> **NCT02508155** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 132 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **BIOLOGICAL:** MEDI7352 for IV infusion
- **BIOLOGICAL:** Placebo for IV infusion
- **BIOLOGICAL:** MEDI7352 for Subcutaneous Injection
- **BIOLOGICAL:** Placebo for Subcutaneous Injection

## Key facts

- **NCT ID:** NCT02508155
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-17
- **Primary completion:** 2020-12-23
- **Final completion:** 2020-12-23
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02508155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02508155, "A Study of MEDI7352 in Painful Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02508155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*